Related Experiment Video
Updated: Jun 24, 2026

In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity
Published on: January 29, 2018
Modulation of inducible nitric oxide synthase expression by sumoylation
Candan A Akar1, Douglas L Feinstein
1Department of Anesthesiology, University of Illinois, Chicago, IL 60612, USA. candan@uic.edu
Inflammation reduces SUMOylation in astrocytes, impacting nitric oxide synthase type 2 (NOS2) expression. Noradrenaline (NA) counteracts this, suggesting SUMOylation and C/EBPbeta modification as therapeutic targets for neurological diseases.
Area of Science:
- Neuroscience
- Molecular Biology
- Immunology
Background:
- Inflammatory induction of nitric oxide synthase type 2 (NOS2) in astrocytes is transcriptionally inhibited by noradrenaline (NA).
- The precise transcription factors modulated by NA and SUMOylation in this process remain unclear.
- SUMOylation, a post-translational modification, influences transcription factor activity, including C/EBPbeta, crucial for NOS2 expression.
Purpose of the Study:
- To investigate the impact of inflammation and NA on SUMOylation-related genes (SRGs) in astrocytes.
- To determine if SUMO-1 regulates NOS2 expression through interaction with C/EBPbeta.
Main Methods:
- Primary astrocytes were treated with lipopolysaccharide (LPS) to induce inflammation and NOS2 expression.
- mRNA levels of SUMO-1, Ubc9, and SENP1 were quantified using QPCR.
- Functional roles of SUMOylation were assessed via reporter gene assays, chromatin immunoprecipitation (ChIP), and co-immunoprecipitation with FRET analysis.
Main Results:
- LPS decreased SRG mRNA levels in astrocytes; NA attenuated these reductions and increased SUMO-1.
- Over-expression of SRGs modulated NOS2 promoter activity, with SUMO-1 uniquely affecting NFkappaB reporter activity.
- ChIP and FRET assays confirmed interactions between SUMO-1, C/EBPbeta, and the NOS2 promoter, modulated by LPS and NA.
Conclusions:
- SUMOylation significantly regulates NOS2 expression in astrocytes.
- Modification of the transcription factor C/EBPbeta by SUMO-1 is a likely mechanism.
- Targeting the SUMOylation pathway presents a potential therapeutic strategy for neurological conditions characterized by inflammatory NOS2 expression.
Related Concept Videos
Nitric Oxide Signaling Pathway
Regulation of Expression at Multiple Steps
Regulation of Nuclear Protein Sorting
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...

